Katie Falloon, MD: Studying IBD-Associated Peripheral Arthritis
Falloon said IBD-associated peripheral arthritis is common, but not well understood.
Kendall Beck, MD: Promising New Tofacitinib Data From the Crohn's and Colitis Congress
Dose de-escalation of tofacitinib resulted in less hospitalizations for patients with ulcerative colitis.
Laura E. Raffals, MD: Sifting Through All the Drug Choices for IBD
The potential for personalized medicine in inflammatory bowel disease might. be realized in the next few years.
Marlana Radcliffe, MD: Treating Ulcerative Colitis Patients With Upadacitinib After Tofacitinib
Upadacitinib was not approved by the FDA until 2022 for patients with ulcerative colitis.
Diet, Lifestyle Interventions Improve Symptoms, Quality of Life for IBD Patients
The 12-24 session counseling program also resulted in improvements in sleep quality, fatigue level, and stress levels for patients with inflammatory bowel disease.
Persistence Common, Beneficial for Ulcerative Colitis Patients Treated With Ustekinumab
The majority of patients who achieved persistence at the 12 month mark were also corticosteroid free.
A Plant-Based Option to Treat Ulcerative Colitis
The product is a combination of herbal compounds curcumin and QingDai called CurQD.
AI Models Enhance Histological Detection in Ulcerative Colitis Patients
Microscopic inflammation can be an important indicator of disease activity in patients with ulcerative colitis.
